EFALIZUMABUM

EFALIZUMABUM Chemische Eigenschaften,Einsatz,Produktion Methoden

Originator

XOMA (US)

Verwenden

Treatment of transplant rejections; antipsoriatic (immunomodulator monoclonal antibody which decreases the activation, migration, and adhesion of T-cells). hu1124; anti-CD11a.

Trademarks

Raptiva

EFALIZUMABUM Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

EFALIZUMABUM Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
BOC Sciences	16314854226; +8616314854226	inquiry@bocsci.com	United States	19852	58
Aladdin Scientific		tp@aladdinsci.com	United States	54746	58
Wuhan Chemstan Biotechnology Co., Ltd.	027-65317797 15926423062	422450190@qq.com	China	10306	58
Shanghai YuanYe Biotechnology Co., Ltd.	15026964105	2881489226@qq.com	China	89667	60
ShangHai Biochempartner Co.,Ltd	177-54423994 17754423994	2853530910@QQ.com	China	8000	62
Guangzhou Hongyuan Chemical Co.,Ltd	15817493340	981810490@qq.com	China	1577	58
Beijing Jin Ming Biotechnology Co., Ltd.	010-60605840	psaitong@jm-bio.com	China	27602	58
TargetMol Chemicals Inc.	4008200310 15002144251	marketing@tsbiochem.com	China	24951	58
Biolab Reagents	027-65279366 18108604356	products@biolabreagent.com	China	9864	58
Wuhan Jingkangen Biomedical Technology Co., Ltd	13720134139 086-15871494362 13720134139	orders@jknbiochem.com	China	7282	58

---

• EFALIZUMABUM
• Research Grade Efalizumab(DHD41001)
• Efalizumab (anti-ITGAL)
• Hu1124|||HU 1124
• Research Grade Efalizumab
• 214745-43-4